Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary.

Date publication

mai 2021

Journal

Cancers

Auteurs

Membres identifiés du Cancéropôle Est :
Dr GEOFFROIS Lionnel , Dr TOUSSAINT Bruno , Dr FAIVRE Jean-Christophe

Tous les auteurs :
Abu-Shama Y, Salleron J, Carsuzaa F, Sun XS, Pflumio C, Troussier I, Petit C, Caubet M, Beddok A, Calugaru V, Servagi-Vernat S, Castelli J, Miroir J, Krengli M, Giraud P, Romano E, Khalifa J, Doré M, Blanchard N, Coutte A, Dupin C, Sumodhee S, Tao Y, Roth V, Geoffrois L, Toussaint B, Nguyen DT, Faivre JC, Thariat J

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34067697

Résumé

Management of head and neck cancers of unknown primary (HNCUP) combines neck dissection (ND) and radiotherapy, with or without chemotherapy. The prognostic value of ND has hardly been studied in HNCUP.

Mots clés

chemoradiotherapy, head and neck, neck dissection, neoplasms/cancers/carcinomas, prognosis, unknown primary

Référence

Cancers (Basel). 2021 May 17;13(10):